Related Experiment Video
Updated: Jun 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Assessing cardiovascular disease in the dialysis patient
Sara Z Baig1, Walter C Coats, Kul B Aggarwal
1Division of Cardiology, School of Medicine, University of Missouri-Columbia, Columbia, Missouri 65212, USA.
Insights
Patients with end-stage renal disease (ESRD) have high rates of underdiagnosed coronary artery disease (CAD). Cardiac troponin I is the most specific biomarker for diagnosing acute myocardial infarction in these high-risk individuals.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiac mortality is a leading cause of death in end-stage renal disease (ESRD) patients, accounting for nearly half of all deaths.
- Coronary artery disease (CAD) affects a significant portion (38%-40%) of patients initiating dialysis, driven by traditional and kidney disease-specific risk factors.
- CAD, especially acute myocardial infarction (AMI), is frequently underdiagnosed in the ESRD population.
Purpose of the Study:
- To review the prevalence and diagnostic challenges of coronary artery disease (CAD) in patients with end-stage renal disease (ESRD).
- To evaluate the utility of various diagnostic modalities for CAD screening in ESRD patients.
- To identify the most specific biomarker for diagnosing acute myocardial infarction (AMI) in this population.
Main Methods:
- Review of existing literature on cardiovascular disease in ESRD patients.
- Assessment of diagnostic accuracy for coronary artery disease (CAD) using dobutamine stress echocardiography, stress myocardial perfusion imaging, and coronary artery calcium scoring.
- Comparison of cardiac biomarkers including cardiac troponin I, cardiac troponin T, and CK-MB for acute myocardial infarction (AMI) diagnosis.
Main Results:
- Dobutamine stress echocardiography and stress myocardial perfusion imaging are useful for screening coronary artery disease (CAD) in end-stage renal disease (ESRD) patients.
- Coronary artery calcium scoring has limited utility in this population.
- Cardiac troponin I demonstrates higher specificity than cardiac troponin T or CK-MB in diagnosing acute myocardial infarction (AMI) in dialysis patients.
Conclusions:
- Coronary artery disease (CAD) is highly prevalent and often underdiagnosed in end-stage renal disease (ESRD) patients.
- Appropriate screening tools like dobutamine stress echocardiography are crucial for early CAD detection.
- Cardiac troponin I is the preferred biomarker for diagnosing acute myocardial infarction (AMI) in ESRD patients due to its superior specificity.
Abstract:
Cardiac causes account for nearly half of all deaths in patients with end-stage renal disease (ESRD). Coronary artery disease (CAD) is present in 38% - 40% of patients starting dialysis. Both traditional and chronic kidney disease-related cardiovascular risk factors contribute to this high prevalence rate. In patients with ESRD, CAD--particularly acute myocardial infarction--is underdiagnosed. Dobutamine stress echocardiography and, to a lesser extent, stress myocardial perfusion imaging have proved useful in screening for CAD in such patients. Coronary artery calcium scoring is less useful. Acute myocardial infarction is associated with high short- and long-term mortality in dialysis patients. Cardiac troponin I appears to be more specific than cardiac troponin T or CK-MB in the diagnosis of acute myocardial infarction.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Hemodialysis III: Nursing Management
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Assessment of the Cardiovascular System II: Inspection
Head and Neck
